These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

273 related items for PubMed ID: 29700923

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Comparison of therapy persistence for fixed versus free combination antihypertensives: a retrospective cohort study.
    Grimmsmann T, Himmel W.
    BMJ Open; 2016 Nov 22; 6(11):e011650. PubMed ID: 27881519
    [Abstract] [Full Text] [Related]

  • 23. Single-pill vs free-equivalent combination therapies for hypertension: a meta-analysis of health care costs and adherence.
    Sherrill B, Halpern M, Khan S, Zhang J, Panjabi S.
    J Clin Hypertens (Greenwich); 2011 Dec 22; 13(12):898-909. PubMed ID: 22142349
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Single-Pill Triple Fixed Dose Combination Therapy with Single Component Drug Monitoring in Treatment-Resistant Hypertension: A Pilot Study.
    Kreutz R, Scholze J, Douros A.
    Curr Vasc Pharmacol; 2018 Jan 26; 16(2):197-203. PubMed ID: 28828980
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Effectiveness of fixed-dose combination therapy in hypertension: systematic review and meta-analysis.
    Kawalec P, Holko P, Gawin M, Pilc A.
    Arch Med Sci; 2018 Aug 26; 14(5):1125-1136. PubMed ID: 30154897
    [Abstract] [Full Text] [Related]

  • 29. Drug adherence in treatment resistant and in controlled hypertension-Results from the Swedish Primary Care Cardiovascular Database (SPCCD).
    Holmqvist L, Boström KB, Kahan T, Schiöler L, Qvarnström M, Wettermark B, Hjerpe P, Hasselström J, Manhem K.
    Pharmacoepidemiol Drug Saf; 2018 Mar 26; 27(3):315-321. PubMed ID: 29349834
    [Abstract] [Full Text] [Related]

  • 30. [One year adherence of ramipril versus ramipril/amlodipine fixed dose combination therapy in hypertension].
    Simonyi G, Ferenci T.
    Orv Hetil; 2017 Oct 26; 158(42):1669-1673. PubMed ID: 29037057
    [Abstract] [Full Text] [Related]

  • 31. A step in the global effort to control hypertension: Fixed dose combination antihypertensive drugs.
    Campbell NRC.
    J Clin Hypertens (Greenwich); 2019 Sep 26; 21(9):1426-1428. PubMed ID: 31441988
    [Abstract] [Full Text] [Related]

  • 32. Clinical impact of patient adherence to a fixed-dose combination of olmesartan, amlodipine and hydrochlorothiazide.
    Bramlage P, Ketelhut R, Fronk EM, Wolf WP, Smolnik R, Zemmrich C, Schmieder RE.
    Clin Drug Investig; 2014 Jun 26; 34(6):403-11. PubMed ID: 24719291
    [Abstract] [Full Text] [Related]

  • 33. Fixed-dose combination antihypertensives and risk of medication errors.
    Moriarty F, Bennett K, Fahey T.
    Heart; 2019 Feb 26; 105(3):204-209. PubMed ID: 30072364
    [Abstract] [Full Text] [Related]

  • 34. Impact of single-pill combination therapy on adherence, blood pressure control, and clinical outcomes: a rapid evidence assessment of recent literature.
    Tsioufis K, Kreutz R, Sykara G, van Vugt J, Hassan T.
    J Hypertens; 2020 Jun 26; 38(6):1016-1028. PubMed ID: 32371789
    [Abstract] [Full Text] [Related]

  • 35. Medication adherence with fixed-dose versus free-equivalent combination therapies: Systematic review and meta-analysis.
    Wei Q, Zhou J, Li H, Wang L, Wu Y, Ma A, Guan X.
    Front Pharmacol; 2023 Jun 26; 14():1156081. PubMed ID: 37033611
    [Abstract] [Full Text] [Related]

  • 36. Comparison of Efficacies of Commonly Used Hypertension Treatment Modalities: A Retrospective Study of 1900 Participants in a Hypertension Clinic.
    Zhao X, Dahal A, Yang Q, Yang Y, Ding Z, Wang J, Swai JD, Jiang W, Li X.
    Med Sci Monit; 2020 Apr 30; 26():e921211. PubMed ID: 32352950
    [Abstract] [Full Text] [Related]

  • 37. [One year persistence of atorvastatin and amlodipine fixed dose combination versus atorvastatin therapy].
    Simonyi G, Ferenci T.
    Orv Hetil; 2016 Mar 13; 157(11):425-9. PubMed ID: 26947091
    [Abstract] [Full Text] [Related]

  • 38. Who benefits from fixed-dose combinations? Two-year statin adherence trajectories in initiators of combined amlodipine/atorvastatin therapy.
    Schaffer AL, Buckley NA, Pearson SA.
    Pharmacoepidemiol Drug Saf; 2017 Dec 13; 26(12):1465-1473. PubMed ID: 29067759
    [Abstract] [Full Text] [Related]

  • 39. Real-world Antihypertensive Treatment Patterns, Treatment Adherence, and Blood Pressure Control in the Elderly: An Italian Awareness-raising Campaign on Hypertension by Senior Italia FederAnziani, the Italian Society of Hypertension and the Italian Federation of General Practitioners.
    Del Pinto R, Desideri G, Ferri C, Agabiti Rosei E.
    High Blood Press Cardiovasc Prev; 2021 Sep 13; 28(5):457-466. PubMed ID: 34185255
    [Abstract] [Full Text] [Related]

  • 40. A medication adherence and persistence comparison of hypertensive patients treated with single-, double- and triple-pill combination therapy.
    Xie L, Frech-Tamas F, Marrett E, Baser O.
    Curr Med Res Opin; 2014 Dec 13; 30(12):2415-22. PubMed ID: 25222764
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.